Pharma Bio Serv (OTCMKTS:PBSV) and FTI Consulting (NYSE:FCN) are both business services companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, profitability, earnings, institutional ownership and risk.
Pharma Bio Serv pays an annual dividend of $0.08 per share and has a dividend yield of 7.3%. FTI Consulting does not pay a dividend. Pharma Bio Serv pays out -133.3% of its earnings in the form of a dividend.
Risk and Volatility
Pharma Bio Serv has a beta of 0.22, meaning that its share price is 78% less volatile than the S&P 500. Comparatively, FTI Consulting has a beta of 0.08, meaning that its share price is 92% less volatile than the S&P 500.
Insider & Institutional Ownership
99.2% of FTI Consulting shares are owned by institutional investors. 51.6% of Pharma Bio Serv shares are owned by company insiders. Comparatively, 2.2% of FTI Consulting shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
This is a summary of current ratings and recommmendations for Pharma Bio Serv and FTI Consulting, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Pharma Bio Serv||0||0||0||0||N/A|
Earnings & Valuation
This table compares Pharma Bio Serv and FTI Consulting’s top-line revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Pharma Bio Serv||$17.79 million||1.45||$1.27 million||($0.06)||-18.33|
|FTI Consulting||$1.81 billion||1.47||$107.96 million||$2.32||29.82|
FTI Consulting has higher revenue and earnings than Pharma Bio Serv. Pharma Bio Serv is trading at a lower price-to-earnings ratio than FTI Consulting, indicating that it is currently the more affordable of the two stocks.
This table compares Pharma Bio Serv and FTI Consulting’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Pharma Bio Serv||7.07%||7.61%||6.11%|
FTI Consulting beats Pharma Bio Serv on 10 of the 14 factors compared between the two stocks.
About Pharma Bio Serv
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm the United States, Europe, and Brazil markets. It provides compliance consulting services to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products in Puerto Rico, the United States, Europe, and Brazil. The company's technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.
About FTI Consulting
FTI Consulting, Inc. provides business advisory services to manage change, mitigate risk, and resolve disputes worldwide. The company's Corporate Finance & Restructuring segment provides turnaround and restructuring, business transformation, interim management, valuation and financial advisory, transaction, dispute advisory, and tax services, as well as mergers and acquisitions (M&A), and M&A integration services. Its Forensic and Litigation Consulting segment offers anti-corruption investigations and compliance, and data and analytics, as well as compliance, monitoring, and receivership services; cybersecurity, forensic accounting and advisory, and global risk and investigations practice; and construction solutions, dispute advisory, intellectual property, trial, business insurance claims, and health solutions. The company's Economic Consulting segment provides financial, economic, and econometric consulting services; business and expert valuation, and expert testimony services; intellectual property and international arbitration services; economic and statistical analyses services; services related to public policy and regulated industries, and healthcare economics and policy; and network and economic impact analysis, and securities litigation and risk management services. Its Technology segment offers e-discovery management, managed document review, collections and digital forensics, information governance and compliance, investigations, and contract intelligence services, as well as e-discovery software. The company's Strategic Communications segment provides advice services relating to public affairs and government relations, M&A crisis communications and special situations, corporate reputation, people and change, digital and creative communications, capital markets communications, and strategy consulting and research. FTI Consulting, Inc. was founded in 1982 and is headquartered in Washington, District of Columbia.
Receive News & Ratings for Pharma Bio Serv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma Bio Serv and related companies with MarketBeat.com's FREE daily email newsletter.